300015.SHE Aier Eye Hospital Group
- Market cap
- CNY 81.5B
- P/E
- 33.8x
- P/B
- 3.49x
- ROE
- 13.5%
- Dividend yield
- 1.87%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300015.SHE undervalued?
Graham number300015.SHE trades 128.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Aier Eye Hospital Group fundamental analysis
No fundamental analysis for Aier Eye Hospital Group yet.
Aier Eye Hospital Group stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Aier Eye Hospital Group
Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. It offers diagnosis and treatment services for various ophthalmic diseases, and surgical and medical optometry services, as well as lens fitting services for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd. wa…
Full company profileAier Eye Hospital Group financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Aier Eye Hospital Group annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 4.00B | 5.96B | 8.01B | 9.99B | 11.9B | 15.0B | 16.1B | 20.4B | 21.0B | 22.4B | 24.5B |
| Gross Profit | 1.84B | 2.76B | 3.76B | 4.93B | 6.08B | 7.79B | 8.13B | 10.3B | 10.1B | 10.5B | 11.5B |
| Operating Income | 698M | 1.11B | 1.56B | 2.02B | 2.67B | 3.49B | 3.53B | 4.95B | 4.82B | 4.90B | 6.33B |
| EBITDA | 827M | 1.29B | 1.94B | 2.68B | 3.72B | 4.51B | 4.51B | 5.91B | 5.28B | 6.47B | 5.59B |
| Net Income | 557M | 743M | 1.01B | 1.38B | 1.72B | 2.32B | 2.52B | 3.36B | 3.56B | 3.24B | 3.06B |
| EPS | 0.07 | 0.09 | 0.11 | 0.16 | 0.19 | 0.26 | 0.28 | 0.36 | 0.38 | 0.35 | 0.33 |
| Balance Sheet | |||||||||||
| Total Assets | 4.43B | 9.31B | 9.63B | 11.9B | 18.3B | 21.8B | 26.6B | 30.2B | 33.3B | 36.7B | 37.4B |
| Total Liabilities | 1.22B | 3.84B | 3.66B | 4.87B | 7.69B | 9.62B | 8.96B | 10.2B | 11.4B | 13.3B | 13.0B |
| Shareholders' Equity | 3.05B | 5.22B | 5.69B | 6.59B | 9.85B | 11.3B | 16.7B | 18.9B | 20.7B | 22.0B | 22.7B |
| Cash & Short-term Investments | 835M | 2.82B | 1.71B | 2.14B | 3.36B | 4.70B | 6.90B | 6.91B | 6.09B | 5.30B | 5.20B |
| Total Debt | 187M | 1.47B | 1.60B | 2.22B | 4.45B | 3.83B | 4.02B | 4.83B | 6.02B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 675M | 1.33B | 1.40B | 2.08B | 3.34B | 4.08B | 4.49B | 5.87B | 4.88B | 5.97B | - |
| Capital Expenditure | 315M | 606M | 811M | 746M | 894M | 1.49B | 1.39B | 1.46B | 1.83B | 2.09B | 1.24B |
| Free Cash Flow | 361M | 725M | 589M | 1.33B | 2.45B | 2.59B | 3.10B | 4.41B | 3.05B | 3.88B | 4.58B |
| Ratios | |||||||||||
| ROE | 18.2% | 14.2% | 17.7% | 20.9% | 17.5% | 20.5% | 15.1% | 17.8% | 17.2% | 14.7% | 13.5% |
| ROA | 12.6% | 8.0% | 10.5% | 11.6% | 9.4% | 10.6% | 9.5% | 11.1% | 10.7% | 8.8% | 8.2% |
| Net Profit Margin | 13.9% | 12.5% | 12.6% | 13.8% | 14.5% | 15.5% | 15.7% | 16.5% | 16.9% | 14.5% | 12.5% |
| Debt to Equity | 0.06x | 0.28x | 0.28x | 0.34x | 0.45x | 0.34x | 0.24x | 0.26x | 0.29x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Aier Eye Hospital Group dividends
- Dividend yield
- 1.87%
- Forward dividend
- 0.18 CNY
- Payout ratio
- 47.1%
- Ex-dividend date
- Jul 17, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 1.53B | 0.16 | 47.1% |
| 2024 | CNY 1.42B | 0.15 | 39.9% |
| 2023 | CNY 718M | 0.08 | 21.4% |
| 2022 | CNY 649M | 0.07 | 25.7% |
| 2021 | CNY 663M | 0.07 | 28.5% |
| 2020 | CNY 531M | 0.06 | 30.8% |
| 2019 | CNY 477M | 0.05 | 34.6% |
| 2018 | CNY 526M | 0.06 | 52.2% |
| 2017 | CNY 194M | 0.02 | 26.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.300045:1 on Jun 8, 2023.
Who owns Aier Eye Hospital Group
- Insiders 54.55%
- Institutions 5.96%
- Public & others 39.49%
- Shares outstanding 9.28B
- Free float 4.16B
Aier Eye Hospital Group company profile
- Company name
- Aier Eye Hospital Group
- Ticker
- 300015.SHE
- ISIN
- CNE100000GR6
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Oct 30, 2009
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 42,817
- Fiscal year end
- December
- Address
- No. 188, N. Twr of Aier Ophthalmology Bl, Changsha, China, 410015
- Phone
- 86 731 8517 9288
- Website
- aierchina.com
About Aier Eye Hospital Group
Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. It offers diagnosis and treatment services for various ophthalmic diseases, and surgical and medical optometry services, as well as lens fitting services for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China.
Aier Eye Hospital Group management
10- Mr. Bang ChenFounder & Chairman of the Board · born 1965
- Mr. Li LiVice Chairman & GM · born 1965
- Ms. Qiwen MoChief Financial Officer · born 1979
- Mr. Duoyuan LiuDeputy General Manager · born 1962
- Mr. Zhong HanDeputy General Manager · born 1965
- Mr. Shibo TangDeputy General Manager · born 1961
- Mr. Zhi Kuan YangDeputy General Manager · born 1964
- Ms. Li Hua WangDeputy General Manager · born 1974
- Ms. Jun FengDeputy General Manager · born 1979
- Ms. Yan ZhangDeputy General Manager · born 1969